Remove 2023 Remove Doctors Remove Prescription
article thumbnail

Curavit’s crystal ball – how will 2023 drive meaningful changes in clinical research

pharmaphorum

As this collective body of experience continues to proliferate, 2023 will see additional FDA guidance. In 2023, expect to see AI innovations improve enrolment agility and, most importantly, the patient experience in a clinical trial. Beyond 2023 – the Sovereign Patient ID.

FDA 97
article thumbnail

The Weight Loss Medication Dilemma: A Physician’s Perspective

PM360

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.

Medical 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Two Key Questions About Adherence/Compliance in 2023

PM360

What if the industry were to incentivize persistence over new prescriptions? NRx data drives stock prices, determines ROI, and directs bonuses. What if instead of short-term gains, we prioritized the long game? Imagine if we collectively proclaimed that the real value is not only in starting, but in staying.

Medical 98
article thumbnail

Reducing Abandonment on the Path to Prescription

PM360

Technological innovations and changes in consumer behavior over the past 10 years have reduced friction, saved time, and opened new options for consumers and patients seeking routine prescriptions and refills via telehealth. Let’s face it, most consumers seek convenience wherever they can find it.

article thumbnail

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

The Schedule 1 classification means that these substances cannot be administered by doctors and, though they may be used for the purposes of research a government licence is often required. These restrictions provide the first obstacles to scientific research and commercial development.

Medicine 131
article thumbnail

ELITE 2023 Digital Crusader Karina Castagna of OptimizeRx

PM360

Prior to OptimizeRx, while at Amgen, she established the first pharmacy team focused on helping patients and doctors navigate reimbursement hurdles with the top 20 specialty pharmacies in the country. This work helped physicians and patients more easily access Amgen’s therapies resulting in tens of thousands of new patient starts.

article thumbnail

Engaging Patients in More Moments Along Their Care Journey

PM360

More than a quarter of patients (26%) wait two months or more for appointments, according to a 2023 survey from the American Association of Nurse Practitioners. Doctor finder tools, for example, can help patients find care faster based on their unique needs, including location and insurance coverage.